CD137 and CD137 ligand in vascular smooth muscle cells

被引：0
|
作者：
Wågsäter, D.
Olofsson, P. S.
Sirsjö, A.
机构：
[1] Karolinska Inst, King Gustaf V Res Inst, Stockholm, Sweden
[2] Karolinska Inst, Ctr Mol Med, Stockholm, Sweden
[3] Univ Orebro, Inst Clin Med, Orebro, Sweden
来源：
ATHEROSCLEROSIS SUPPLEMENTS | 2006年 / 7卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R6 [外科学];
学科分类号：
1002 ; 100210 ;
摘要：
WeP11216
引用
收藏
页码：393 / 393
页数：1
相关论文
共 50 条
  • [31] Contributions of Costimulatory Molecule CD137 in Endothelial Cells
    Yuan, Wei
    Xu, Chong
    Li, Bo
    Xia, Hao
    Pan, Yingjie
    Zhong, Wei
    Xu, Liangjie
    Chen, Rui
    Wang, Bin
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2021, 10 (11):
  • [32] Therapeutic vaccination with tumor cells that engage CD137
    Karl Erik Hellstrom
    Ingegerd Hellstrom
    Journal of Molecular Medicine, 2003, 81 : 71 - 86
  • [33] CD137 ligand signaling enhances myelopoiesis during infections
    Tang, Qianqiao
    Jiang, Dongsheng
    Alonso, Sylvie
    Pant, Aakansha
    Gomez, Julia M. Martinez
    Kemeny, David Michael
    Chen, Lieping
    Schwarz, Herbert
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2013, 43 (06) : 1555 - 1567
  • [34] The role of CD137 and CD137L in pathogenesis of multiple sclerosis
    Wong, H. Y.
    Schwarz, H.
    GLIA, 2017, 65 : E412 - E412
  • [35] Activation of the CD137 Pathway in T cells by a CD137 x 5T4 bispecific ADAPTIR Molecule Requires Co-engagement of CD137 and 5T4
    Blahnik-Fagan, Gabriele R.
    Bader, Robert
    Bannink, Jeannette
    Mitchell, Danielle
    Misher, Lynda
    McMahan, Cathy
    Bienvenue, David
    Fritzell, Sara
    Sall, Anna
    von Schantz, Laura
    Ellmark, Peter
    Nelson, Michelle
    Hernandez-Hoyos, Gabriela
    JOURNAL OF IMMUNOLOGY, 2018, 200 (01):
  • [36] Role of the CD137 ligand (CD137L) signaling pathway during Mycobacterium tuberculosis infection
    Gomez, Julia Maria Martinez
    Koh, Vanessa Hui Qi
    Yan, Benedict
    Lin, Wenwei
    Ang, Michelle Lay Teng
    Rahim, Siti Zarina Zainul
    Pethe, Kevin
    Schwarz, Herbert
    Alonso, Sylvie
    IMMUNOBIOLOGY, 2014, 219 (01) : 78 - 86
  • [37] Increased Soluble CD137 Levels and CD4+T-Cell-Associated Expression of CD137 in Acute Atherothrombotic Stroke
    He, Yang
    Ao, Dong-Hui
    Li, Xiao-Qing
    Zhong, Shan-Shan
    Rong, A.
    Wang, Yang-Yang
    Xiang, Ya-Juan
    Xu, Bao-Lei
    Yang, Ting-Ting
    Gao, Xu-Guang
    Liu, Guang-Zhi
    CTS-CLINICAL AND TRANSLATIONAL SCIENCE, 2018, 11 (04): : 428 - 434
  • [38] EVALUATION OF EFFICACY AND TOXICITY OF CD137 IMMUNOTHERAPY WITH URELUMAB-MIGG1 CHIMERIC ANTIBODY IN CD137 HUGEMM™
    Zhang, Hongjuan
    He, Daniel
    Zhang, Mingkun
    Feng, Xinhe
    An, Annie
    Ju, Cunxiang
    Li, Henry
    Ouyang, Davy
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2020, 8 : A388 - A388
  • [39] Involvement of CD137 ligand signaling in neural stem cell death
    Yun, Chang Ho
    Lee, Hye Myeong
    Lee, Sang Chul
    Kim, Byung Sam
    Park, Jeong Woo
    Lee, Byung Ju
    MOLECULES AND CELLS, 2013, 36 (03) : 245 - 251
  • [40] CD137: A checkpoint regulator involved in atherosclerosis
    Soderstrom, Leif A.
    Tarnawski, Laura
    Olofsson, Peder S.
    ATHEROSCLEROSIS, 2018, 272 : 66 - 72
12345